Morcos S K, Thomsen H S, Webb J A
Department of Diagnostic Imaging, Northern General Hospital NHS Trust, Sheffield, S5 7AY, UK.
Eur Radiol. 2001;11(9):1720-8. doi: 10.1007/s003300000778.
The aim of this study was to document, using consensus methodology, current practice for prevention of generalized reactions to contrast media, to identify areas where there is disagreement or confusion and to draw up guidelines for reducing the risk of generalized contrast media reactions based on the survey and a review of the literature. A document with 165 questions was mailed to 202 members of the European Society of Urogenital Radiology. The questions covered risk factors and prophylactic measures for generalized contrast media reactions. Sixty-eight members (34%) responded. The majority indicated that a history of moderate and severe reaction(s) to contrast media and asthma are important risk factors. The survey also indicated that patients with risk factors should receive non-ionic contrast media. In patients at high risk of reaction, if the examination is deemed absolutely necessary, a resuscitation team should be available at the time of the procedure. The majority (91%) used corticosteroid prophylaxis given at least 11 h before contrast medium to patients at increased risk of reaction. The frequency of the dosage varied from one to three times. Fifty-five percent also use antihistamine Hl, mainly administered orally and once. Antihistamine H2 and ephedrine are rarely used. All essential drugs are available on the emergency resuscitation trolley. Patients with risk factors are observed up to 30 min by 48% and up to 60 min by 43% of the responders. Prophylactic measures are not taken before extravascular use of contrast media. Prophylactic drugs are given to patients with a history of moderate or severe generalized reaction to contrast media. In patients with asthma, opinion is divided with only half of the responders giving prophylactic drugs. Aspirin, beta-blockers, interleukin-2 and non-steroid anti-inflammatory drugs are not considered risk factors and therefore are not stopped before injection of contrast media. The survey showed some variability in rating of risk factors for generalized contrast medium reactions, and marked variability in the prophylactic measures used. There remain major areas of uncertainty, and there is insufficient data in the literature to guide practice. Some simple guidelines for prophylaxis of generalized contrast medium reactions are proposed.
本研究的目的是采用共识方法记录当前预防造影剂全身反应的实践情况,识别存在分歧或困惑的领域,并根据调查和文献综述制定降低造影剂全身反应风险的指南。一份包含165个问题的文件被邮寄给了202名欧洲泌尿生殖放射学会成员。这些问题涵盖了造影剂全身反应的危险因素和预防措施。68名成员(34%)做出了回应。大多数人指出,有造影剂中度和重度反应史以及哮喘是重要的危险因素。调查还表明,有危险因素的患者应使用非离子型造影剂。对于反应高危患者,如果检查被认为绝对必要,操作时应配备复苏团队。大多数人(91%)对反应风险增加的患者在造影剂注射前至少11小时给予皮质类固醇预防。给药频率从一次到三次不等。55%的人还使用H1组胺拮抗剂,主要经口服给药一次。很少使用H2组胺拮抗剂和麻黄碱。所有必需药物都备在急救复苏推车上。48%的受访者对有危险因素的患者观察30分钟,43%的受访者观察60分钟。在血管外使用造影剂之前不采取预防措施。对有造影剂中度或重度全身反应史的患者给予预防性药物。对于哮喘患者,意见不一,只有一半的受访者给予预防性药物。阿司匹林、β受体阻滞剂、白细胞介素-2和非甾体抗炎药不被视为危险因素,因此在注射造影剂前无需停用。调查显示,在造影剂全身反应危险因素的评级方面存在一些差异,在使用的预防措施方面存在明显差异。仍存在主要的不确定性领域,文献中也没有足够的数据来指导实践。本文提出了一些预防造影剂全身反应的简单指南。